Research @ UVA Engineering

Kimberly Kelly uses computational methods and bioinformatics to develop more effective and less toxic cancer drugs through the identification of disease-relevant druggable targets, with a special emphasis on translation to the clinic and commercialization.

Kelsey Kubelick leverages light, sound, nanoconstruct design and cellular engineering strategies to develop advanced theranostic imaging platforms. With a special interest in ultrasound and photoacoustics, her lab creates imaging tools that play a critical role in informing, guiding and enhancing therapies across a range of biomedical applications.

Kyle Lampe is an Associate Professor in the Department of Chemical Engineering at the University of Virginia, and by courtesy, Biomedical Engineering and Neuroscience.

Kristen Naegle uses data- and computational-driven approaches to predict, and experimental approaches to test, the regulation and function of tyrosine phosphorylation in complex networks.

For the past 35+ years, Blair has been a pharmaceutical manufacturing, quality, and development executive where he has had the opportunity to work globally and drive twelve new chemical/biological and biosimilar products through development and into sustained commercial production. 

Shayn Peirce-Cottler develops computational models and combines them with wet lab experiments and machine learning to study how tissues heal after injury and to develop new therapies for inducing tissue regeneration.

Dr. Price's research program centers on the development and implementation of image-guided drug and gene delivery systems for treating cancer and neurodegenerative diseases.

Jeff Saucerman, PhD, Professor of Biomedical Engineering, combines computational models and high-throughput experiments to discover molecular networks and drugs that control cardiac remodeling.